advertisement

---

Ishida K 9

Showing records 1 to 9 | Display all abstracts from Ishida K

90766 Evaluation of bleb characteristics after trabeculectomy and glaucoma implant surgery in rabbit
Ishida K
Ophthalmic Research 2021; 64: 68-76

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Tsukahara S; Enomoto N
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90766 Evaluation of bleb characteristics after trabeculectomy and glaucoma implant surgery in rabbit
Nakano Y
Ophthalmic Research 2021; 64: 68-76

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Ishida K
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90766 Evaluation of bleb characteristics after trabeculectomy and glaucoma implant surgery in rabbit
Ojino K
Ophthalmic Research 2021; 64: 68-76

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Anraku A
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90766 Evaluation of bleb characteristics after trabeculectomy and glaucoma implant surgery in rabbit
Shimazawa M; Otsuka T
Ophthalmic Research 2021; 64: 68-76

---

90701 One-Year Efficacy and Safety Assessment of Ripasudil, a Rho Kinase Inhibitor, in an Addition to or Replacing Existing Treatment Regimens: A Retrospective Study
Tomita G
Journal of Ocular Pharmacology and Therapeutics 2020; 36: 512-521

---

90766 Evaluation of bleb characteristics after trabeculectomy and glaucoma implant surgery in rabbit
Inagaki S; Kawase K; Hara H; Yamamoto T
Ophthalmic Research 2021; 64: 68-76

---